Calculating the economic burden of presumed microbial keratitis admissions at a tertiary referral centre in the UK.
George MoussaJames HodsonNick GoochJasvir S VirdeeCristina PenalozaJesse KigoziSaaeha RauzPublished in: Eye (London, England) (2020)
LOS is the key driver for COA of care for MK admissions. Protocols should encourage discharge of patients who are able to self-administer treatment after the sterilisation phase. The MOG-derived data collection toolset captures pertinent clinical data for quantification of COA. Further development into a multiuser and multisite platform is required for robust prospective testing, together with expansion to capture indirect costs of disease burden, including impact of treatment, visual morbidity and quality of life.
Keyphrases
- end stage renal disease
- healthcare
- electronic health record
- ejection fraction
- primary care
- newly diagnosed
- chronic kidney disease
- big data
- palliative care
- peritoneal dialysis
- microbial community
- fatty acid
- prognostic factors
- cross sectional
- combination therapy
- replacement therapy
- patient reported outcomes
- pain management
- health insurance
- artificial intelligence
- data analysis